IPO Profile: Xenon Pharmaceuticals Inc

Canadian biotech company launched a $36 million on the Nasdaq

1 December 2014•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.